Monday, March 30, 2009


Just when I thought that I could forget about this issue, along comes another story.

Using rosuvastatin as the trial base, an American research [from New England] study claims to cut the risk of things like deep vein thrombosis and pulmonary embolism. Other varieties of Statins haven't been tested in this study but you can be certain that they will be included in any recommendations made by the medical profession.

RosuvastatinImage via Wikipedia

The researchers claim that "aggressive Statin therapy reduces life-threatening blood clots in the veins" and that this "carried no risk of excess bleeding...associated with alternative blood-thinning treatments such as warfarin". What isn't mentioned is that Statins have all kinds of other health risks and as such they should be applied to treatments on an individual basis, rather than the blanket prescribing system that is being promoted at the moment.

The suggestion is that Statins should be prescribed on a prophylactic basis to all those considered to be at risk from DVT or whatever. My fear is that this will probably be extended to include everyone in time.

The feeling I am getting is that the chemical manufacturers are really getting desperate to dump their waste by-products in a 'non-polluting way' and are planning to rely on us to do it for them, so many medicines are already entering the waste system that it would be fairly easy to add more - what this will do to the environment is anybodies guess.

Yours, in fairly deep distrust of anything the 'health' profession is trying to push on us.


Reblog this post [with Zemanta]

No comments: